The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.
Polymorphic RNA conformations may serve as potential targets for structure specific antiviral agents. As an initial step in the development of such drugs, the interaction of a wide variety of compounds which are characterized to bind to DNA through classical or partial intercalation or by mechanism of groove binding, with the A-form and the protonated form of poly(rC).poly(rG), been evaluated by multifaceted spectroscopic and viscometric techniques. Results of this study suggest that (i) ethidium intercalates to the A-form of RNA, but does not intercalate to the protonated form, (ii) methylene blue intercalates to the protonated form of the RNA but does not intercalate to the A-form, (iii) actinomycin D does not bind to either conformations of the RNA, and (iv) berberine binds to the protonated form by partial intercalation process, while its binding to the A-form is very weak. The DNA groove binder distamycin A has much higher affinity to the protonated form of the RNA compared to the A-form and binds to both structures by non-intercalative mechanism. We conclude that the binding affinity characteristics of these DNA binding molecules to the RNA conformations are vastly different and may serve as data for the development of RNA based antiviral drugs.
Sinha
Rangana
R
Biophysical Chemistry Laboratory, Indian Institute of Chemical Biology, Kolkata 700 032, India.
Islam
Md Maidul
MM
Bhadra
Kakali
K
Kumar
Gopinatha Suresh
GS
Banerjee
Anamika
A
Maiti
Motilal
M
D001599:Berberine / Q000737:chemistry / Q000378:metabolism; D001665:Binding Sites; D002942:Circular Dichroism; D003609:Dactinomycin / Q000737:chemistry / Q000378:metabolism; D004214:Distamycins / Q000737:chemistry / Q000378:metabolism; D004996:Ethidium / Q000737:chemistry / Q000378:metabolism; D005454:Fluorescence Polarization; D066298:In Vitro Techniques; D007364:Intercalating Agents / Q000737:chemistry* / Q000378:metabolism*; D008751:Methylene Blue / Q000737:chemistry / Q000378:metabolism; D011066:Poly C / Q000737:chemistry* / Q000378:metabolism*; D011068:Poly G / Q000737:chemistry* / Q000378:metabolism*; D011522:Protons; D013053:Spectrophotometry; D013056:Spectrophotometry, Ultraviolet; D014783:Viscosity
D004214:Distamycins; D007364:Intercalating Agents; D011522:Protons; D001599:Berberine; D003609:Dactinomycin; D011068:Poly G; C008961:poly G-poly C; D011066:Poly C; C030000:stallimycin; D004996:Ethidium; D008751:Methylene Blue